NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/05/2024
Back to search
Official data from USPTO
EMED SCREEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EMED SCREEN
ST13
US500000097806709Class
1, 5, 42
Filing
97806709
Registration
7560506
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
11/05/2024
Trademark type
Word
Nice classes
1, 5, 42
Filing date
02/22/2023
Registration date
11/05/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/05/2024
Last transaction
11/05/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/01/2023
First use in commerce
03/01/2023
Drawing code
4
Owner type
16
Owner location
Miami, FL, US
Examiner
XU, ELAINE YILIN
Law office
N90
Current location
TMO LAW OFFICE 127
Holders and representatives
Holders
EMED, LLC
Representatives
Thomas Y. Yee Perkins Coie LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic kits consisting primarily of reagents and antibodies to detect drugs for drug screening except for medical or veterinary use; Rapid drug screening tests comprised of diagnostic and chemical reagents for the simultaneousqualitative detection of multiple drugs and metabolitesnot for medical or veterinary purposes
Class 5
Diagnostic preparations for medical purposes; test kits for diagnostic purposesmedical diagnostic test strips for use in the field of the detection of drugs; rapid drug screening tests comprised of diagnostic and chemical reagents for the simultaneousqualitative detection of multiple drugs and metabolitesfor medical purposes
Class 42
Providing on-linenon-downloadable internet-based software for use in detectingscreening and monitoring the presence of drugs; providing temporary use of on-linenon-downloadable cloud-based software for use in detectingscreening and monitoring the presence of drugs; software as a service (SAAS) services featuring software for use in detectingscreening and monitoring the presence of drugs; platform as a service (PAAS) featuring computer software platforms for detectingscreeningmonitoring the presence of drugs; providing on-linenon-downloadable internet-based software for use in connection with data and information managementreceiptstoragedisplaytrackingsharingmanagementmonitoringanalysis; providing on-linenon-downloadable cloud-based software for use in connection with data and information managementreceiptstoragedisplaytrackingsharingmanagementmonitoringanalysis; software as a service (SAAS) services featuring software for use in connection with data and information managementreceiptstoragedisplaytrackingsharingmanagementmonitoringanalysis; platform as a service (PAAS) featuring computer software platform for use in connection with data and information managementreceiptstoragedisplaytrackingsharingmanagementmonitoringanalysis; software as a service (SAAS) services featuring software for providing a non-downloadable online platform that enables video conferencing connectivity between proctors and users; software as a service (SAAS) services featuring software for live digital communicationslive video and audio conferencing with multiple simultaneous usersteleconferencingnetwork conferencing; software as a service (SAAS) services featuring software for providing a non-downloadable online platform to enable workflow management of a proctored examination; software as a service (SAAS) services featuring software for providing a non-downloadable online platform to enable video conferencing connectivity between proctors and users to conduct a proctored test; platform as a service (PAAS) featuring computer software platforms for proctoring of exams; platform as a service (PAAS) featuring computer software platforms for providing online identity verification services and for creating identity verification reports; platform as a service (PAAS) featuring computer software platforms for providing process verification services for businesses and for creating process verification reports; providing temporary use of non-downloadable cloud based software as a service (SAAS) servicescomprising AI-enabled proctoring to ensure integrity of remote assessments with real-time imageaudiovideo proctoringassessing functionalprogrammingtechnical and communication skills in real-time with video interviewspreventing cheating using AIconducting video interviews; software as a service (SAAS) services featuring software for secure exam proctoring and content protectionidentification verificationdata analytics associated therewith; software as a service (SAAS) services featuring software for providing proctored examination testingexamination monitoringfor reporting examination and testing results to government agenciesinsurersemployerscompaniesusers; providing temporary use of on-line non-downloadable cloud-based computer software for autonomous online proctoring and identity verification; providing temporary use of online non-downloadable software for enabling video conferencing connectivity between proctors and users; software as a service (SAAS) services featuring software for providing a non-downloadable online platform that enables users to order diagnostic teststo take diagnostic tests online with the guidance of a proctorto view and access test resultsto order pharmaceuticals and prescriptions; software as a service (SAAS) services featuring software for providing a non-downloadable online platform that enables AI-based guidance through self-administered diagnostic tests; software as a service (SAAS) services featuring software for providing an online platform that enables users to access digital health results; Providing document and identity verification servicesproviding remote identity document scanning being electronic scanning of personally identifying photographic imagesphoto scanningdigitization of documentsdata extraction being data encryptiondata decryptionall of the foregoing in the field of authentication and verification services being provided via a website; computer security services in the nature of screening of individuals by administering digital certificates for personal identity verification services provided through digital identification technology to authenticate user identity; Screening of individuals in the nature of using video to verify personal identity of users to authenticate user identity of test takers; Screening of individuals in the nature of using a personalized code to verify personal identity of users to authenticate user identity of test takers; screening of individuals in the nature of providing non-downloadable mobile access and web-based platforms featuring technology for personal identity verification to authenticate user identity; providing user authentication of personal identifying information using single sign-on technology via secure storage and transmission of supporting evidence via the internet for use with online software applications; providing user authentication services for personal identifying information using single-sign on technology via video conference for use with online software applications; none of the foregoing for use in emergency medicine and none of the foregoing for training medical professionals
Publications
History of USPTO decisions and trademark events.
28 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/05/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/27/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/27/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/23/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/23/2024
IUAF
USE AMENDMENT FILED
06/28/2024
EISU
TEAS STATEMENT OF USE RECEIVED
06/28/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/25/2024
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
05/19/2024
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
02/06/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/09/2024
PUBO
PUBLISHED FOR OPPOSITION
01/09/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/20/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/04/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
12/04/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/04/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
12/04/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/04/2023
DOCK
ASSIGNED TO EXAMINER
11/03/2023
DOCK
ASSIGNED TO EXAMINER
10/31/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/10/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/10/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/10/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/10/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/10/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/14/2023
NWAP
NEW APPLICATION ENTERED
02/25/2023
Continuous trademark protection
Get notified about every new filing that threatens EMED SCREEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.